Dear Colleagues,
The 2021 Virtual Introductory Training Course on
'Pharmacokinetics and Pharmacodynamics of Protein Therapeutics - Principles &
Pharmacometric Approaches'
will be held on December 1-3, 2021.
The 3-day course continues on the successful concept used in previous year
offerings. It will introduce participants to basic principles in the
pharmacokinetic and pharmacodynamic evaluation of novel therapeutic proteins
and will provide PK and PK/PD modeling and simulation examples relevant to
therapeutic proteins. Topics include target-mediated drug disposition,
interspecies scaling, first-in-human dose selection, model-informed drug
development, pediatric pharmacology, drug-drug interactions, and
immunogenicity. The target audience comprises pharmaceutical scientists from
industry, academia and regulatory agencies with basic knowledge in PK and PKPD
that had only limited exposure to the challenges associated with developing
therapeutic proteins and that would like to receive a comprehensive overview or
refresher on the PK and PKPD of this class of compounds.
Although the course includes some hands-on exercises, participants do NOT need
to have prior experience with any particular PKPD analysis software.
For more detailed information on the preliminary course program and timing, as
well as on the registration process, please visit
http://www.PKPDofProteinTherapeutics.com
We hope you will join us in December!
The Course Directors
Bernd Meibohm & Johan Gabrielsson
Bernd Meibohm, PhD, FCP, FAAPS
Associate Dean for Research & Graduate Programs
Interim Chair, Department of Pharmaceutical Sciences
UTHSC Distinguished Professor
The University of Tennessee Health Science Center
College of Pharmacy
Pharmacy Building, Suite 435
881 Madison Avenue
Memphis, TN 38163, USA